Summary of Key Points
Hanwang Technology is the leader in sales in the Chinese electronic paper tablet market (with a 19.6% share in the first half of 2026), but it has been in the red for four and a half years, accumulating a loss of 663 million yuan. On one hand, it has the best-selling products; on the other hand, its financial situation continues to deteriorate. The root of this contradiction lies in the following factors: its new businesses (such as AI blood pressure monitors and biomimetic robots) are still in the cost-intensive development phase and have not yet generated profits. The company’s research and development (R&D) efforts are spread too thinly, failing to create a core competitive advantage. Its products are sold at low prices, resulting in thin margins. Additionally, the rapid transformation of its competitors is squeezing its market space, preventing it from converting its technology into tangible financial benefits.
Detailed Analysis
1. Why doesn’t a top-selling company make money? High sales volume, but low prices
You might think that being the number one seller would mean high profits, but Hanwang’s situation is the opposite. Although its electronic paper tablets are the most sold, the sales revenue was taken by iFlytek, which ranked fourth. According to data from LoTu Technology, Hanwang had a 19.6% market share in the first half of 2026, but it did not lead in sales revenue. This is like selling 100 buns for 1 yuan each, while someone else sells 50 buns for 3 yuan each—your total profit is less.
The reason is that Hanwang’s products have lower average prices and lack the ability to compete in the high-end market. For example, its e-books and laptops may have similar features to iFlytek’s, but they are more affordable, which reduces the profit margin. Moreover, due to fierce industry competition, Hanwang may have to lower prices to maintain sales, further squeezing its profits.
2. Where does the money go? Heavy investment in new businesses with no returns
Hanwang’s losses have been gradual over the past four and a half years. In the first half of 2026, it invested 138 million yuan in R&D, accounting for 16.6% of its revenue (a significant proportion for tech companies). However, the money is spread too thinly across various projects, such as AI blood pressure monitors, biomimetic flying devices, odor recognition, and facial recognition systems, without any one area achieving significant success. For instance, the biomimetic robots are still in the laboratory stage, and the AI blood pressure monitor has just passed the US FDA approval but has not yet started mass production. These investments do not show immediate returns.
Compared to its competitors, Hanwang’s R&D budget is much smaller—iFlytek spent 5.3 billion yuan on R&D in 2025, while Hanwang only spent 310 million yuan. This lack of focus and sufficient investment prevents Hanwang from building a competitive advantage.
3. Old businesses struggling, new businesses failing to take off
Hanwang’s main business, “intelligent pen interactions” (e.g., handwriting recognition, electromagnetic pens), accounts for over 60% of its revenue, but it faces increasing competition from similar products, leading to lower gross margins. The much-anticipated AI-powered smart devices business generated only 235 million yuan in the first half of 2026, showing no growth.
New businesses, such as the AI blood pressure monitor, have potential, but they are still in the early stages. The AI blood pressure monitor has obtained FDA approval, but its overseas launch is pending, and there is no guarantee of immediate sales success. With its mature businesses declining and new businesses failing to thrive, Hanwang’s revenue structure is at risk.
4. Competitors moving forward, leaving Hanwang behind
The overall sales volume in the electronic paper tablet market is declining, and competitors are seeking new opportunities:
- Zhanyue Technology: shifted from e-books to AI-generated short videos, with revenue increasing by 41% in the first half of 2026;
- iFlytek: leverages its scale to dominate the high-end smart laptop market;
- Wenshi BOOX: develops its own color electronic paper technology to compete in the high-end e-reader market.
Hanwang, stuck in the traditional e-book market, lacks new growth drivers and a foothold in the high-end market, making it increasingly vulnerable to competition.
5. Where is the turning point? Still figuring out how to turn technology into profit
Hanwang is trying to find solutions, such as introducing incubated projects into a “business partner program” to attract external funding and resources for monetization. New businesses like AI-based products have generated some revenue, but a stable profit model has not yet been established. However, the success of these efforts is uncertain. The AI blood pressure monitor’s overseas launch and the biomimetic robots’ commercialization will take time.
The stock market’s lack of confidence is evident: Hanwang’s stock price fell by nearly 40% in August 2026 compared to the beginning of the year.
In summary, Hanwang possesses valuable technology, but transforming it into a sustainable profit source remains an unsolved challenge.